Definitive Contract HHSD200201688486C
Award Date 12/18/15
Potential Completion Date 2/28/17
Potential Value $12M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,620,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Novartis Vaccines and Diagnostics, Inc. for the "2016 ADULT FLU" program. The contract has a firm fixed price pricing type and an ultimate completion date of February 28, 2017. It is not a set-aside contract. This contract may be related to the CDC's efforts to provide vaccines and diagnostics for influenza preparedness and response, but additional details about the specific...
- This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Novartis Vaccines and Diagnostics, Inc. for the procurement of flu vaccines. The contract has a ceiling value of $78,000.00 and a completion date of August 15, 2015. The contract was awarded on June 23, 2015 and was not set aside for any specific business type. Novartis Vaccines and Diagnostics, Inc. is a foreign-owned, for-profit manufacturer of goods that is registered in the System...
- This is a $44,980,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the production and delivery of influenza vaccines. The contract, which does not have a set-aside designation, covers the 2017 adult flu season with a completion date of February 28, 2018. Seqirus, through its Seqirus USA, Inc. division, is a major supplier of influenza vaccines to various federal government...
- This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Novartis Vaccines and Diagnostics, Inc. for the supply of flu vaccines. The contract has a ceiling value of $114,400.00 and a period of performance through December 31, 2015. The contract was awarded on June 9, 2015 and is not designated as a set-aside. Novartis Vaccines and Diagnostics, Inc. is a foreign-owned, for-profit manufacturer of goods that is registered in the System for...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency of the U.S. government, to Novartis Vaccines and Diagnostics, Inc. for the provision of flu vaccine. The contract has a ceiling value of $79,300.00 and an ultimate completion date of October 15, 2015. The contract was awarded on June 24, 2015 and does not have a set-aside designation. As the prime contractor, Novartis Vaccines and Diagnostics, Inc. is a...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of pharmaceutical goods. The $540,787,384.50 firm fixed price contract is for the provision of 2017 pediatric flu vaccines, with a performance period ending on February 28, 2018. This award is not associated with a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines and pharmaceuticals to various U.S. government...
- This is a $83,765,821.70 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. for the provision of 2016 adult influenza vaccines. The contract is a firm fixed-price award without any set-aside designation, with a period of performance ending on February 28, 2017. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of pharmaceuticals and medical supplies, and has provided a range of vaccine products and services to federal agencies...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Novartis Vaccines and Diagnostics, Inc. for the delivery of flu vaccines. The contract has a ceiling value of $114,400.00 and was awarded on June 22, 2015, with a final completion date of December 31, 2015. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. Novartis Vaccines and Diagnostics, Inc. is the prime contractor, and the place of...
- This is a firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The contract, valued at $303,100.00, is for the delivery of adult flu vaccines during the 2016-2017 flu season. The contract does not have a set-aside designation. Seqirus USA Inc. is the prime contractor and has been awarded multiple Indefinite Delivery Contracts (IDCs) by the CDC, Department of...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 22 (VISN 22), a civilian agency within the U.S. Department of Veterans Affairs, to Novartis Vaccines and Diagnostics, Inc., a foreign-owned for-profit manufacturing company. The contract, valued at $197,600.00, is for the delivery of flu vaccines. The contract has an ultimate completion date of December 31, 2015 and does not have a set-aside designation. No information about major subcontractors...